Skip to main content
SWOG logo

User account menu

  • Log in

Main navigation

  • About
    • History & Impact
    • Mission & Values
    • Leadership
    • Support SWOG
    • Join SWOG
    • Policies & Procedures
    • Careers
    • Contact Us
  • The SWOG Network
    • How We Work
    • Our Staff
    • Our Advocates
    • Our Partners
  • News & Events
    • News
    • SWOG Stories
    • SWOG Meetings
    • For Press
  • Clinical Trials
    • Biospecimen Submission
    • Biospecimen Access
    • Clinical Trials Search
    • Clinical Research Resources
    • Frequently Asked Questions
    • Publications
    • Institutions
    • Quality Assurance & Audits
    • Serious Adverse Events
    • Training Resources
    • CRA Workbench
    • Protocol Workbench
  • For Patients
    • Patient & Advocate Voices
    • Trials Open to Patients
    • About SWOG Cancer Trials
    • Joining a Trial

Breadcrumb

  1. SWOG
  2. News & Events
  3. News

News

SIGN UP FOR EMAIL UPDATES
S0931 Analysis at ESMO 2023
Press Release
Oct 21, 2023

Adjuvant Benefit in Highest Risk Clear-Cell RCC

SWOG Front Line banner
The Front Line
Oct 20, 2023

SWOG’s Fall 2023 Group Meeting Is a Wrap

SWOG Front Line banner
The Front Line
Sep 29, 2023

How an Idea Becomes a Trial

SWOG Front Line banner
The Front Line
Sep 15, 2023

Top Ten Resources for SWOG Committee Chairs

SWOG Front Line banner
The Front Line
Sep 8, 2023

SWOG Site Principal Investigators: A Primer

Lung-MAP: A lung cancer precision medicine trial
Press Release
Sep 7, 2023

Lung-MAP Broadens Trial Access for Some Groups

SWOG Front Line banner
The Front Line
Sep 1, 2023

Member Highlight: MAVERIC VA Storefront

SWOG Front Line banner
The Front Line
Aug 25, 2023

Trial Summaries for Our Patients: Ahora en español

SWOG Front Line banner
The Front Line
Aug 11, 2023

Cutting Edge Science Merits Cutting Edge Technology

  • Previous page ‹
  • First page 1
  • …
  • Page9
  • Current page10
  • Page11
  • …
  • Last page 61
  • Next page ›
SWOG logo

Footer: Social Links

  • LinkedIn
  • Twitter
  • YouTube
Copyright © 2025

Footer

  • Disclaimer